Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Oral Cavity”

1,886 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,886 results

Testing effectiveness (Phase 2)Ended earlyNCT00400205
What this trial is testing

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Who this might be right for
Squamous Cell CarcinomaOral Cancer
Emory University 14
Large-scale testing (Phase 3)Study completedNCT00960440
What this trial is testing

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
Pfizer 399
Not applicableNot Yet RecruitingNCT07260617
What this trial is testing

Association Between Composition of the Gut Microbiota and Nutritional Status in Digestive Oncology

Who this might be right for
Digestive Cancer
Hospices Civils de Lyon 150
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Large-scale testing (Phase 3)Active Not RecruitingNCT04173533
What this trial is testing

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasia
University of Birmingham 326
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableUnknownNCT00983697
What this trial is testing

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

Who this might be right for
Head and Neck Cancer
American College of Radiology Imaging Network 292
Early research (Phase 1)Study completedNCT00478725
What this trial is testing

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT00551850
What this trial is testing

A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients

Who this might be right for
Advanced CancerRefractory Cancer
AVEO Pharmaceuticals, Inc. 37
Early research (Phase 1)Study completedNCT00826878
What this trial is testing

An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AVEO Pharmaceuticals, Inc. 17
Early research (Phase 1)Not Yet RecruitingNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03370276
What this trial is testing

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more
H. Lee Moffitt Cancer Center and Research Institute 95
Early research (Phase 1)Study completedNCT01756118
What this trial is testing

A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Myelocytic, AcuteChronic Myelogenous Leukemia With Crisis of Blast Cells
Goethe University 24
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Testing effectiveness (Phase 2)Looking for participantsNCT06533657
What this trial is testing

Unique Treatment of Oncology Pain in Advanced Cancer

Who this might be right for
Cancer Pain
ZYUS Life Sciences Inc. 20
Not applicableStudy completedNCT05400057
What this trial is testing

The Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients

Who this might be right for
Oral Lichen PlanusOral Cancer
Moataz Mahmoud 60
Large-scale testing (Phase 3)Study completedNCT02555501
What this trial is testing

Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy

Who this might be right for
Oral Mucositis
Universidade Ceuma 18
Large-scale testing (Phase 3)Study completedNCT04887506
What this trial is testing

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer
Tavanta Therapeutics 107
Post-approval studies (Phase 4)Not Yet RecruitingNCT05841849
What this trial is testing

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Who this might be right for
Breast CancerChemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, School of Medicine, Zhejiang University 1,028
Early research (Phase 1)Ended earlyNCT01283178
What this trial is testing

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Who this might be right for
Salivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Hypopharynx+13 more
Virginia Commonwealth University 3
Load More Results